Ainos(us:AIMD)

0.4852

-1.22%

Updated on 2025-04-02

Open:0.5100
Close:0.4852
High:0.5198
Low:0.4800
Prev Close:0.4912
Volume:58567.00
Turnover:28675.47
Turnover Ratio:0.38%
Shares:15.43M
MarketCap:7.49M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3012872271.18%225
2024-03-31101087121.77%520
2023-12-3111172020.37%117
2023-09-3010272390.13%421
2023-06-309411770.20%015
2023-03-31101198620.82%422
2022-12-318574650.29%133
2022-09-307710300.36%700
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Two Sigma Securities, Llc255860.42%25586
2024-03-31Boothbay Fund Management, Llc250000.41%25000
2024-03-31Blackrock Inc.153250.25%0
2024-03-31Susquehanna International Group, Llp126280.21%12628
2024-03-31Ubs Group Ag114820.19%11482
2024-03-31Geode Capital Management, Llc102010.17%10201
2024-03-31Tower Research Capital Llc (Trc)84650.14%6608355.84%
2024-03-31Wells Fargo & Company/Mn150.00%550.00%
2024-03-31Cwm, Llc70.00%0
2024-03-31Osaic Holdings, Inc.30

About

Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its medtech solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA. The company was founded on June 26, 1984 and is headquartered in San Diego, CA.
Address:8880 Rio San Diego Drive,Suite 800

Market Movers